Clinical Trials Directory

Trials / Conditions / ALL, Adult

ALL, Adult

15 registered clinical trials studyying ALL, Adult — 4 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingDaratumumab for T Cell ALL With MRD-positive After Standard Chemotherapy
NCT06570915
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 2
UnknownVideo-recOrded hospItal dischaRge (VOIR)
NCT06512272
Anglia Ruskin UniversityN/A
RecruitingRDC-Blinatumomab Versus hyperCVAD for Ph-negative B-ALL.
NCT06250959
Chen SuningPhase 2
Active Not RecruitingA Study of BN104 in the Treatment of Acute Leukemia
NCT06052813
Institut de Recherches Internationales Servier (I.R.I.S.)Phase 1 / Phase 2
CompletedOptimising Pharmacist-led Medication Reviews in Primary Care
NCT05928104
University of East Anglia—
RecruitingCharacterizing Sleep Among Long-term Survivors of Childhood Cancer
NCT05480904
St. Jude Children's Research Hospital—
RecruitingA Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Tra
NCT05473910
TScan Therapeutics, Inc.Phase 1
Active Not RecruitingSequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+
NCT04722848
Gruppo Italiano Malattie EMatologiche dell'AdultoPhase 3
UnknownA Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALL
NCT05024357
First Affiliated Hospital Xi'an Jiaotong UniversityN/A
UnknownA Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL
NCT05026229
First Affiliated Hospital Xi'an Jiaotong UniversityN/A
Active Not RecruitingPalliative Care Oncology in Patients With Relapsed, Refractory, and High-Risk Leukemias or MDS
NCT04482894
University of VirginiaPhase 2
CompletedCOVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being
NCT04357041
Clinical Nutrition Research Center, Illinois Institute of Technology—
CompletedBlinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALL
NCT03751709
Cedars-Sinai Medical CenterPhase 1
TerminatedA Phase I Study of CYC140, a PLK-1 Inhibitor, in Advanced Leukemias or MDS
NCT03884829
Cyclacel Pharmaceuticals, Inc.Phase 1
Active Not RecruitingBlinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults
NCT03541083
Stichting Hemato-Oncologie voor Volwassenen NederlandPhase 2